Most Clicked StoriesMore >

Valeant raises prices on drugs in 3 classes

PCMA SmartBrief | Oct 17, 2016

Valeant Pharmaceuticals is raising list prices by 2% to 9% for its gastrointestinal, neurology and urology drugs, effective immediately. The company raised prices on its eye drugs by 9.9% in September. The Wall Street Journal (tiered subscription model) (10/14)

PCMA President Mark Merritt: Drugmakers attempt to deflect blame for pricing strategies

PCMA SmartBrief | Oct 19, 2016

CMS releases star ratings for MA plans with drug coverage, Part D

PCMA SmartBrief | Oct 17, 2016

Medicaid pharmacy modernization could save $51B

PCMA SmartBrief | Oct 21, 2016

Pfizer to launch Remicade biosimilar

PCMA SmartBrief | Oct 18, 2016

PCMA President Mark Merritt: PBMs part of high drug price solution

PCMA SmartBrief | Oct 18, 2016

12 in Texas charged in alleged $100M Tricare fraud scheme

PCMA SmartBrief | Oct 17, 2016

Walgreens, Rite Aid extend merger date

PCMA SmartBrief | Oct 20, 2016

Competition in insulin market might stabilize prices

PCMA SmartBrief | Oct 17, 2016

Drugmakers steadily hike prices for MS drugs

PCMA SmartBrief | Oct 17, 2016

Find PCMA SmartBrief Issues by Date:

Sign up for PCMA SmartBrief

Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more